Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
Bear HD; Tang G; Rastogi P; Geyer CE Jr; Robidoux A; Atkins JN; Baez-Diaz L; Brufsky AM; Mehta RS; Fehrenbacher L; Young JA; Senecal FM; Gaur R; Margolese RG; Adams PT; Gross HM; Costantino JP; Swain SM; Mamounas EP; Wolmark N; The New England Journal Of Medicine, 2012, vol. 366, issue 4, p 310, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation